Healthcare TrendsCRISPR Technology Market, 2027 – ResearchAndMarkets.comBusiness Wire (press release)The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry … Continue reading
Healthcare TrendsCRISPR Technology Market, 2027 – ResearchAndMarkets.comBusiness Wire (press release)The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry … Continue reading
Technology NetworksCell & Gene Therapy 2018Technology NetworksSMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October. … Continue reading
Global CRISPR Technology Market 2018-2027 – Focus on Product, Applications, Geographical Analysis, Industry …GlobeNewswire (press release)The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and othe… Continue reading
Technology NetworksNew Target for Immunotherapy for Solid Tumors?Technology NetworksNews Apr 25, 2018 | Original story from University of Cincinnati. New Target for Immunotherapy for Solid Tumors? Breast Tumor Microenvironment. Credit: Joseph Szulczews… Continue reading
STAT |
Early trials of stem–cell therapies hint at potential to restore some vision
STAT n certain eye diseases, cells that are crucial for vision die off, with no innate way to rebuild their supply. But scientists around the world are increasingly deploying treatments derived from stem cells, placing them in patients’ eyes in hopes of … Utah Stem Cells: Stop Joint PainKUTV 2News Scientists generate an atlas of the human genome using stem cellsDrug Target Review Stem Cell Assisted Surgery Now Helping Patients With Insurance Covered Procedures in ArizonaBenzinga |
|
Experimental arthritis drug prevents stem cell transplant complication
Science Daily “Transplanted donor stem cells — and more specifically, the T cells in the donor stem cell product — are particularly good at fighting off leukemia, but these cells can go haywire, unfortunately, and attack the patient’s healthy tissues, causing … |